Skip to main content

and
  1. Article

    Open Access

    Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools

    In chronic-phase chronic myeloid leukemia (CML), tyrosine kinase inhibitors (TKIs) are the standard of care, and treatment-free remission (TFR) following the achievement of a stable deep molecular response (DM...

    Fausto Castagnetti, Gianni Binotto, Isabella Capodanno, Atto Billio in Targeted Oncology (2021)

  2. Article

    Open Access

    Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report

    Silicone implants have been successfully used for breast augmentation and reconstruction in millions of women worldwide. The reaction to the silicone implant is highly variable; it can lead to local inflammato...

    Oswald Moling, Andrea Piccin, Martina Tauber in Journal of Medical Case Reports (2016)

  3. No Access

    Article

    SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma

    In this project, we produced drug-specific recommendations targeting the use of new agents for multiple myeloma (MM). We used the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) syste...

    Giovanni Barosi, Giampaolo Merlini, Atto Billio, Mario Boccadoro in Annals of Hematology (2012)